Stocktoria
Stoke Therapeutics, Inc. STOK
Stoke Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 5,409,169 | $73.1M | 9.13% |
| CITADEL ADVISORS LLC | 499,301 | $16.3M | 0.84% |
| MILLENNIUM MANAGEMENT LLC | 261,028 | $8.5M | 0.44% |
| TWO SIGMA INVESTMENTS, LP | 62,371 | $2.0M | 0.11% |
| D. E. Shaw & Co., Inc. | 57,847 | $1.9M | 0.1% |
| AQR CAPITAL MANAGEMENT LLC | 26,449 | $865,411 | 0.04% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.